港股创新药概念股持续走低，歌礼制药-B跌超7%

Group 1 - The Hong Kong stock market for innovative drug concept stocks is experiencing a decline, with notable drops in various companies [1] - Gilead Sciences-B has fallen over 7%, while companies such as Kanglong Chemical, Innovent Biologics, and Kelaiying have decreased by more than 5% [1] - Other companies like Fosun Pharma, Tigermed, and Rongchang Biologics have also seen declines of over 4% [1]